At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...

Merck (MRK) recently revised its 2025 sales guidance to a range of $64.3 billion to $65.3 billion, acknowledging a slight foreign exchange impact, while also announcing lower year-over-year earnings ...

MRK targets $3B in annual savings by 2027 as it cuts jobs and refocuses investment ahead of Keytruda's 2028 patent cliff.

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...